Get a free sample of Nicotinamide Adenine Dinucleotide Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Nicotinamide Adenine Dinucleotide Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Nicotinamide Adenine Dinucleotide Market Size
Nicotinamide Adenine Dinucleotide Market size was recorded at over USD 488 million in 2021. Driven by changing lifestyle choices, the industry is expected to grow at around 13% CAGR from 2022 to 2030.
Nicotinamide adenine dinucleotide or NAD is attaining positive attention due to its varied health benefits, such as improving athletic performance, reducing chronic fatigue syndrome, managing high cholesterol, treating depression, controlling high blood pressure, helping in anti-aging, maintaining the effects of alcohol on the liver, and more. Mounting utilization and demand from pharmaceuticals are likely to foster nicotinamide adenine dinucleotide market growth over 2022-2030.
Consistent R&D initiatives to improve the effectiveness of NADH or NAD+ on the metabolism to offer therapeutic intervention in inflammatory disorders are contributing substantially to the product adoption rate. For instance, a May 2022 study on NAD metabolism in the immune response, autoimmunity, and inflammageing, funded by the Spanish Ministry of Science and Innovation, concluded that stimuli timing, dosage, and the cellular metabolic state, together with the form of NAD+ supplementation result in the increased global level of NAD+.
Government regulations on dosage may restrain industry progression
Stringent government norms regarding dosage to prevent adverse health effects are foreseen to restrain industry expansion. As NAD works differently depending on the dosage and therapy, the government agencies of various countries have only given it OTC categorization. Nonetheless, advancements in food grade NAD in the form of immunity boosters are set to proliferate the demand for nicotinamide adenine dinucleotide supplements, thereby enabling companies to overcome this issue.
Why is the NAD market share growing from anti-aging products applications?
The anti-aging products application segment is anticipated to expand at 14.5% CAGR through 2030 owing to the rising popularity of skincare and cosmetics products.
How big is the pharmaceutical grade nicotinamide adenine dinucleotide industry?
The pharmaceutical grade NAD segment is poised to reach a valuation of more than USD 515 million by 2030 as a result of numerous benefits of the product as an anti-depressant, an anti-aging solution, and for improving cell restoration.
What is the nicotinamide adenine dinucleotide market size?
Global Market size for Nicotinamide Adenine Dinucleotide was valued at more than USD 488 million in 2021 and is set to progress at around 13% CAGR over the next 8 years.
Which factors will aid the expansion of the Europe nicotinamide adenine dinucleotide market?
Europe market is slated to reach over USD 330 million in revenue by 2030 as a result of the strong presence of pharmaceutical manufacturers that are providing advanced functional beverage products in the region.